Cite

HARVARD Citation

    Genovese, M. et al. (2018). Two years of sarilumab in patients with rheumatoid arthritis and an inadequate response to MTX: safety, efficacy and radiographic outcomes. Rheumatology. pp. 1423-1431. [Online]. 
  
Back to record